A detailed history of Wells Fargo & Company transactions in Nutri Band Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,750 shares of NTRB stock, worth $6,807. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,750
Previous 100 1650.0%
Holding current value
$6,807
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.84 - $9.25 $6,336 - $15,262
1,650 Added 1650.0%
1,750 $10,000
Q2 2024

Aug 13, 2024

BUY
$3.35 - $6.16 $211 - $388
63 Added 170.27%
100 $0
Q1 2024

May 10, 2024

BUY
$2.3 - $4.52 $2 - $4
1 Added 2.78%
37 $0
Q4 2023

Feb 09, 2024

BUY
$1.93 - $3.02 $3 - $6
2 Added 5.88%
36 $0
Q2 2023

Aug 15, 2023

BUY
$2.04 - $3.86 $4 - $7
2 Added 6.25%
34 $0
Q4 2022

Feb 13, 2023

SELL
$3.53 - $4.5 $14 - $18
-4 Reduced 11.11%
32 $0
Q3 2022

Nov 14, 2022

BUY
$3.49 - $7.83 $6 - $15
2 Added 5.88%
36 $0
Q2 2022

Aug 12, 2022

BUY
$2.81 - $5.69 $8 - $17
3 Added 9.68%
34 $0
Q1 2022

May 16, 2022

BUY
$3.3 - $9.43 $3 - $9
1 Added 3.33%
31 $0
Q4 2021

Feb 14, 2022

BUY
$3.14 - $10.08 $94 - $302
30 New
30 $0

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $30.4M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.